100Xfounder
Get Featured

Emulate is focused on commercializing Organs-on-Chips. Healthcare Biotech

About Emulate

The Problem Emulate addresses a core healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.

The Solution Emulate is focused on commercializing Organs-on-Chips. Healthcare Biotech In practice, Emulate centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.

Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Emulate is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Culture The team operates in a fast-paced environment focused on healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.

Why it Matters

Emulate matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Emulate is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Funding Snapshot

Total Funding: $82.00MLast Round: Series E Founders Fund, $82M Series E in 2021All Rounds: 1
  • Series EFounders Fund, $82M Series E in 2021

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

PythonGCPBigQueryReact

Last updated: February 23, 2026

Emulate intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to Emulate.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Emulate

Common questions people ask about this profile.

What is Emulate?

Emulate is focused on commercializing Organs-on-Chips. Healthcare Biotech

Who founded Emulate?

Emulate is associated with Emulate Team on 100Xfounder.

Where is Emulate located?

Emulate is listed in Boston, Massachusetts, USA.

What stage is Emulate in?

Emulate is currently mapped to Series E. Funding context: Founders Fund, $82M Series E in 2021

What is the latest funding round of Emulate?

Emulate's latest tracked round is Series E Founders Fund, $82M Series E in 2021. Total tracked rounds: 1.

Is Emulate hiring now?

Emulate hiring status: Open Roles.

What technologies does Emulate use?

Emulate is associated with Python, GCP, BigQuery, and React.

Is Emulate verified on 100Xfounder?

Yes. Emulate is currently marked verified on 100Xfounder as of March 3, 2026.

How can users connect with Emulate founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.